When doctors talk about BMPR2, a gene that helps control how blood vessels in the lungs grow and stay healthy. Also known as bone morphogenetic protein receptor type 2, it’s not something most people hear about—until it’s broken. If BMPR2 doesn’t work right, your lungs’ blood vessels can narrow and stiffen, forcing your heart to work harder. This isn’t just a theory—it’s the root cause of hereditary pulmonary arterial hypertension, or PAH, in about 70% of families with the condition.
People with a faulty BMPR2 gene don’t always get sick right away. Some live their whole lives without symptoms. But if you have a family history of early-onset lung or heart problems—especially before age 50—this gene could be the hidden thread. It’s not contagious. It’s not caused by smoking or diet. It’s inherited. And if you carry the mutation, your risk of developing PAH jumps from less than 1% to around 20%. That’s why genetic testing matters, not just for you, but for your siblings, kids, and parents.
BMPR2 doesn’t work alone. It’s part of a bigger system that includes other genes like ACVRL1 and ENG, which also affect blood vessel health. When BMPR2 fails, it messes up signals that tell cells to stop growing. The result? Too much tissue builds up in small lung arteries, raising pressure and straining the right side of your heart. You won’t feel it at first. But over time, shortness of breath, fatigue, and swelling in your legs can creep in. That’s when things get serious.
Right now, there’s no cure for BMPR2-related PAH. But treatments are getting better. Drugs like endothelin receptor antagonists and prostacyclin analogs help manage symptoms. New research is looking at gene therapy, targeted drugs, and even ways to turn the broken gene back on. And if you know you carry the mutation, early monitoring can catch changes before they become life-threatening.
What you’ll find in the posts below isn’t a textbook on genetics. It’s real-world info from people who’ve been there. You’ll see how BMPR2 connects to other conditions like hereditary hemorrhagic telangiectasia, how testing works, what it means for family planning, and why some people with the mutation never develop PAH at all. This isn’t about fear. It’s about knowing what’s possible—and what you can do next.
Explore the hereditary side of pulmonary arterial hypertension, key genes like BMPR2, testing options, and how family history impacts risk management.
More